Blog

How Fentanyl Gets From a Chemical Shipment to the Street

Fentanyl is a manufacturing problem with a supply chain, and every link, from precursors to laundering, is a place where policy can bite.

4Republican Staff · Published June 11, 2026

Nobody ever harvested fentanyl. There is no fentanyl field, no fentanyl orchard, no season when the crop comes in. Heroin starts with a poppy and cocaine starts with a leaf, and both of those crops can be spotted from the air and burned. Fentanyl starts with a shipment of industrial chemicals and ends with a pill, and in between there is a production line. That single fact changes how you should think about the crisis, because a production line has suppliers, workers, equipment, customers and cash flow. Anything with a supply chain can be attacked at more than one place.

This is the part of the story that the shouting on cable news leaves out. The debate sounds as if the only question is whether the stuff comes over a fence or through a booth. The more useful question is how it is made, who makes it, and where it is cheapest to stop. This post walks the chain from the first chemical to the last dollar, using what federal prosecutors have laid out in public indictments and what Congress put into law in 2024. I will tell you where I am describing what prosecutors allege and where I am describing settled fact.

Fentanyl is a synthetic opioid first made by the Belgian chemist Paul Janssen in 1959. It has legitimate medical uses in controlled hospital settings, and it is listed as a Schedule II controlled substance in the United States, which is the category for drugs with accepted medical use and a high potential for abuse. Nothing about that is secret.

What makes it a smuggler's dream is its potency. Because a tiny amount carries enormous effect, a small, light package holds a very large number of doses. For a smuggling organization, that means high value per ounce, low bulk, and a product that is easy to hide. The economics are the opposite of marijuana, which is bulky and smelly. This is why fentanyl displaced so much of the older drug trade.

Because it is made in a lab, it can be made anywhere there is a chemist, equipment and ingredients. That is both the danger and the opportunity. The danger is that it is hard to eradicate a lab the way you eradicate a field. The opportunity is that every lab depends on ingredients that have to come from somewhere.

The ingredients are called precursors. They are chemicals that go into making the finished drug, and many have uses in legitimate industry. Federal law gives the Drug Enforcement Administration authority to list chemicals that are used to make illegal drugs and to regulate their handling. Over the years, DEA has added chemicals commonly used in fentanyl production to its control lists.

Public indictments and Justice Department announcements have described a pattern in which companies in China sell precursor chemicals, sometimes openly through online marketing, and ship them to buyers in Mexico and elsewhere. Prosecutors have charged Chinese chemical companies and executives in cases announced in 2023 and after. Remember the legal point: an indictment is an accusation, and defendants are presumed innocent. But the picture drawn by the filings is consistent, and it matches what law enforcement officials have said for years.

Why does this link matter? Because a precursor is a chokepoint. Every batch of fentanyl needs them. They have to be bought, shipped, declared or mis-declared, and stored. Each step leaves paper: invoices, shipping records, payments, websites. A prosecutor can follow paper in a way that a patrol agent cannot follow a footprint in the desert.

Next, the chemicals reach a lab. In the cases prosecutors have described, much of the synthesis happens in Mexico, where criminal organizations run clandestine laboratories. These operations are not kitchen setups. They are industrial in scale, with trained workers, protective equipment, and enough output to supply a continental market.

The Sinaloa Cartel is the best-documented example in public court records. Its former leader, Joaquín "El Chapo" Guzmán, was convicted in federal court in Brooklyn in February 2019 and later sentenced to life in prison. That case concerned a drug empire in an earlier era, mostly cocaine, heroin and marijuana. In April 2023, federal prosecutors in the Southern District of New York announced charges against members of the Chapitos, a faction led by his sons, along with associates, alleging a massive fentanyl production and trafficking operation, with precursors sourced from overseas. Again, those are allegations until proven.

A lab is a better target than a smuggler on foot, because it is fixed, expensive and hard to replace. Mexican authorities have conducted lab raids over the years, and U.S. and Mexican cooperation on those operations is a central diplomatic question, which I cover further in the context of the broader Western Hemisphere. A government that wants to cut supply has to ask whether its neighbor will act, and what leverage persuades it to do so.

Here is where the story becomes deadly for ordinary families. A large share of the fentanyl in the American market is not sold as fentanyl. It is pressed into pills made to look like legitimate prescription medicines. Traffickers buy tablet presses, which are ordinary manufacturing machines, along with dies that stamp markings on the pills. A common counterfeit mimics a prescription painkiller and carries the same kind of stamp as a pharmacy product.

This matters for two reasons. The first is the disguise. A buyer who thinks he is getting a pharmacy-grade pill is getting something else entirely, and that deception is a feature of the business model. The second is a problem of consistency. When a powder this potent is mixed into a batch of pills by crude methods, the amount in each pill can vary widely. The Drug Enforcement Administration has warned about that variability for years. I am not giving anyone medical advice here. I am describing the manufacturing reality: nobody in a clandestine lab is running quality control.

For the policy question, the pill press is another chokepoint. Presses, dies and the raw materials that go with them can be tracked, regulated, and sometimes intercepted. Federal law already regulates the sale of certain tablet presses and encapsulating machines, and enforcement of those rules is an underused tool.

Once pills or powder cross into the United States, they enter a distribution network, and this is where the local and federal prosecutors do their work. The product moves from bulk loads through regional distributors to street-level dealers, and increasingly through social media and encrypted messaging apps that let sellers reach buyers directly.

This is the link that most families encounter, even without knowing it. The seller in your town is the end of a chain that began in a chemical plant on another continent. Going after that seller matters, because the last link is where harm meets a person. But it is also the most replaceable link. Arrest a dealer and another appears, which is why I keep saying that a strategy that only works at the street is playing defense on the least efficient square of the board.

Every link in this chain gets paid, and the payments have to be moved without alerting the authorities. This is money laundering, and it is a business in its own right. Criminal organizations need ways to turn cash from street sales into legitimate funds in bank accounts, and then to move that money to the people who supplied the chemicals and ran the labs.

Federal investigators and Treasury officials have described networks that specialize in laundering for the cartels, including operators who match the cartels' dollars in the United States with people overseas who want to move money out of countries with currency controls. The techniques can be complex, but the principle is simple: the cartel has cash in America, and someone else needs dollars abroad, so the two sides trade through a middleman who takes a fee.

Congress addressed this directly. The FEND Off Fentanyl Act was signed in April 2024. It gave the government more authority to sanction foreign persons involved in fentanyl trafficking and its financing, and it strengthened tools against laundering. If you want the mechanics of how an order from Washington becomes a frozen bank account, I explain them in How Sanctions Work, From a Presidential Order to a Frozen Bank Account. The honest assessment of sanctions is mixed, which I examine in When Sanctions Worked, When They Failed, and Why the Difference Matters, but the money link is the most vulnerable one for an organization that wants to enjoy its profits.

The thread that connects fentanyl and the border

Now the part that brings it back to the immigration debate. Drug smuggling and human smuggling run along the same routes and are often controlled by the same organizations. The groups that dominate territory near the border can profit by moving drugs, moving people and charging others for passage through ground they control. Prosecutors and border officials have said this for years.

That does not mean every person who crosses is a drug carrier, and it would be a lie to say so. It means that the border is a place where organized crime makes money in several ways, and that controlling the border helps cut off more than one revenue stream. It also means that conservatives who want to talk about fentanyl and conservatives who want to talk about illegal crossings are talking about the same criminal organizations. For the layered argument on the ports and the barrier, see They Say a Wall Can't Stop Fentanyl. Here Is the Whole Answer, and for the legal framework on illegal entry itself, see Is Crossing the Border Illegally a Crime? Eleven Answers From the U.S. Code.

Here is the chain again with the tool that fits each link.

  1. Precursors: control lists, enforcement against chemical sellers, diplomatic pressure on producing countries.
  2. Labs: pressure on and cooperation with the Mexican government, intelligence on lab locations, and prosecutions of leaders.
  3. Pill presses: regulation and tracking of tablet-making equipment and dies.
  4. Border crossing: scanning and officers at ports, barriers and agents between them.
  5. Distribution: local and federal prosecution of sellers and the networks that supply them.
  6. Money: sanctions, anti-laundering enforcement, and bulk-cash laws.

The point of listing them is to correct the idea that there is one silver bullet. A chain breaks when you cut it in several places, and a smuggler can reroute around any single cut. The strongest approach pressures every link at once and pays the most attention to the ones that are cheapest to cut and hardest to replace.

The best objection: "Supply-side enforcement never works"

Any honest treatment owes you the strongest objection to everything above, so here it is. Critics of supply-side strategy argue that the drug war has been fought for fifty years and that every time one source is squeezed, another appears. Close one lab and another opens. Sanction one laundering network and a new one forms. As long as there are buyers, the argument goes, sellers will find a way. The only lasting solution, they say, is to reduce demand through treatment, prevention and education.

There is truth in that. Supply chains are resilient, and a policy that counts seizures as success can mistake activity for results. Demand matters, and states and communities that fund prevention and recovery programs are doing real work. A conservative should be glad to support those, and faith-based and community groups have long been at the center of that effort.

But the objection proves too much. If enforcement never mattered, then no one would care that a pound of precursor chemical costs money, or that a trafficker faces risk. In practice, every enforcement action raises costs and risks, and a higher cost means fewer shipments, a smaller margin and a harder time recruiting. The right comparison is not "enforcement versus treatment." It is a family choosing to lock the front door and also talk with the kids. You do both, and you do not accept the claim that doing one excuses the other.

There is also a plain point of justice. The people who run these networks are profiting from products that kill customers who were often deceived about what they were taking. Prosecuting them is not a mere exercise in supply control. It is the government doing its most basic job, which is to protect the public from people who prey on it. That job does not depend on whether a given policy lowers the national numbers by a particular amount. Murder prosecutions do not stop all murders, and nobody concludes that we should stop prosecuting murder.

What a family can do with this

Information is the thing you can take away. Start by knowing how the system works so you can tell a serious proposal from a slogan. Then talk to your own representative and senators, ask them what they have done on precursor controls and on funding for port inspection, and check their record in the bills and votes pages. The cartels have lawyers and accountants. Citizens should have at least a clear picture of the facts.

The bottom line

  • Fentanyl is made, not grown, so it has a supply chain: precursor chemicals, labs, pill presses, smuggling, distribution and laundering. Each link is a target.
  • Public indictments, such as the April 2023 charges against Sinaloa Cartel figures, describe precursors from overseas feeding Mexican labs. Remember that indictments are allegations until proven.
  • The FEND Off Fentanyl Act of April 2024 added sanctions and anti-laundering tools. Ask your representatives how they voted and what they want done next.
  • Human and drug smuggling often run through the same organizations and routes, so border control and drug control are linked, not rivals.
  • Reject the single-fix pitch. A serious plan works the chain at every link, and that is the standard to apply to anyone who asks for your vote.

Latest on this topic